Health Catalyst News

Evercore Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsOct 8 08:31 ET

Health Catalyst Analyst Ratings

BenzingaSep 20 10:57 ET

Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target

BenzingaSep 20 10:57 ET

CCORF Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsSep 20 07:32 ET

J.P. Morgan Maintains Health Catalyst(HCAT.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsSep 4 08:31 ET

CCORF Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsSep 3 08:33 ET

Buy Rating Affirmed on Health Catalyst Amid Positive Growth and Strategic Initiatives

TipRanksSep 3 07:47 ET

Health Catalyst Analyst Ratings

BenzingaAug 26 11:37 ET

Piper Sandler Maintains Health Catalyst(HCAT.US) With Buy Rating, Cuts Target Price to $11

Moomoo NewsAug 26 07:31 ET

Health Catalyst Analyst Ratings

BenzingaAug 20 10:51 ET

Barclays Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsAug 19 06:31 ET

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)

TipRanksAug 19 06:15 ET

Health Catalyst (HCAT) Receives a Buy From Barclays

TipRanksAug 12 03:53 ET

Health Catalyst Price Target Maintained With a $16.00/Share by Cantor Fitzgerald

Dow JonesAug 9 11:38 ET

Cantor Fitzgerald Remains a Buy on Health Catalyst (HCAT)

TipRanksAug 9 08:57 ET

Health Catalyst Analyst Ratings

BenzingaAug 8 13:11 ET

Igniting Growth: Health Catalyst's Strong Trajectory Justifies a Buy Rating

TipRanksAug 8 09:10 ET

Barclays Keeps Their Buy Rating on Health Catalyst (HCAT)

TipRanksAug 8 08:16 ET

Health Catalyst Analyst Ratings

BenzingaJul 9 11:06 ET

Strong Recovery and Expansion Forecast Justifies Buy Rating for Health Catalyst

TipRanksJul 1 06:09 ET